You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

SARS-CoV-2

Test Information
Home / Tests / Critical Infectious Diseases / Xpert Xpress SARS-CoV-2/Flu/RSV

Xpert® Xpress SARS-CoV-2/Flu/RSV*

Actionable rapid respiratory results to meet the challenges of the ongoing pandemic

Ordering Info
Xpert<sup>®</sup> Xpress SARS-CoV-2/Flu/RSV*

The Need


  • Detection and differentiation of flu, RSV, and COVID-19 which all present with similar symptoms
  • Insights for effective triage and patient management
  • Risk assessment for patients and staff while resuming traditional healthcare procedures
  • Identify potential cases of co-infections during respiratory season
  • Current flu and SARS-CoV-2 therapies need definitive diagnosis for each pathogen

The Solution


  • Actionable detection of SARS-CoV-2, Flu A, Flu B, and RSV in as little as 25 minutes^
  • Actionable on-demand results with 1 sample collection
  • Optimizes GeneXpert® System module capacity by combining 2 Xpress tests into 1
  • Standardization of results between the central lab and near patient testing sites

The Impact


  • Empower patients with rapid results to help keep their loved ones and the community safe
  • Assist hospitals to effectively manage limited resources
  • Provide labs with single-test confidence to accelerate workflows
  • Support clinicians with on-demand, timely, and accurate results

*For Use Under an Emergency Use Authorization (EAU) only. This test has not been FDA cleared or approved; this test has been authorized by FDA under an EUA for use by authorized laboratories; this test has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acids from SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV), and not for any other viruses or pathogens; and this test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

^ For positives when running SARS-CoV-2 only on Xpress SARS-CoV-2/Flu/RSV; otherwise, the test will have a runtime of approximately 36 minutes.

Ordering Info


Xpert® Xpress SARS-CoV-2/Flu/RSV*

Catalog #: XPCOV2/FLU/RSV-10
Back to Top